LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Nov 12, 2020

Keywords

ClinConnect Summary

The LAAC-registry study is researching the outcomes of a procedure called left atrial appendage (LAA) closure in patients with a heart condition known as atrial fibrillation (AF). This condition can increase the risk of blood clots and stroke, so the study aims to compare the results of this procedure across different groups of patients to see how well it works and to gather important information for future care.

To join this study, participants need to be at least 18 years old and have been diagnosed with non-valvular atrial fibrillation, which means their AF is not caused by issues with heart valves. They should also have a certain score that indicates a higher risk for stroke. The study is currently recruiting participants, and anyone interested will be asked to give their written consent to be part of the research. If you join, you can expect to undergo the LAA closure procedure and be monitored afterwards to help researchers understand how effective it is for different people. This study is important because it aims to improve treatment for those at risk of stroke due to atrial fibrillation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age\> 18
• • Written informed consent to participate in the study
• • Patients with paroxysmal, persistent, or permanent non-valvular AF and CHA2DS2-VASc Score of ≥2 that are planned for an elective LAA-closure
• • Anatomic characteristics allow placement of a CE marked device, dedicated for LAAC
• Exclusion Criteria:
• • None. Considering the nature of the project, which is to prospectively collect information on all patients treated with LAAC in our center, we will only exclude patients unwilling to sign the informed consent.